Table 1 Characteristics and quality scores of included studies
NO | Author | Year | Country | Study design | Biopsy method | Guiding needle | Biopsy needle | Guidance method | Blood status | Blood patch group | Control group | Quality scores | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patients | Age (years) | Lesion size (cm) | Patients | Age (years) | Lesion size (cm) | |||||||||||
1 | Lang | 2000 | American | RCT | Aspiration biopsy | 19G | 20G–22G | Conventional CT | Clotted | 50 | 54 | 2.0 | 50 | 48 | 2.4 | 3* |
2 | Malone | 2013 | American | RCT | Core biopsy | 17G or 19G | 18G or 20G | Conventional CT | Clotted | 123 | 65 | 2.2 | 119 | 66 | 2.3 | 7* |
3 | Clayton | 2016 | American | Retrospective cohort study | Aspiration biopsy or core biopsy | 19G | 20G,22G, 23G | Conventional CT | Non-clotted | 245 | 67 | 2.3 | 189 | 66 | 2.3 | 8# |
4 | Graffy | 2017 | American | Retrospective cohort study | Aspiration biopsy or core biopsy | 17G-21G 65.6%19G | 20G or21G | Fluoroscopy CT | Non-clotted | 482 | 66.2 | – | 352 | 63.4 | – | 7# |
5 | Perl | 2019 | Germany | Retrospective cohort study | Core biopsy | 13G, 15G, 17G,19G | – | Conventional CT | Non-clotted | 419 | – | – | 449 | 63.4 | – | 7# |
6 | Turgut | 2020 | Turkey | Retrospective cohort study | Core biopsy | 19G | 20G | Conventional CT | Non-clotted | 91 | 62.6 | 3.2 | 171 | 59.3 | 3.0 | 9# |
7 | Mendoza | 2020 | American | Retrospective cohort study | Core biopsy | – | 99%20G | – | – | 64 | – | – | 124 | – | – | Unclear |
8 | Jain | 2022 | American | Retrospective cohort study | Core biopsy | 17G or19G 98.5%19G | 98.5%20G | Conventional CT | Clotted | 309 | 69 | – | 227 | 68 | – | 8# |
9 | Duignan | 2023 | Ireland | Prospective and Retrospective cohort study | Core biopsy | 19G | 20G | Fluoroscopy CT | Non-clotted | 259 | 68.4 | 2.4 | 393 | 68.1 | 2.8 | 7# |